averkie_skila

Preference for EMA`s over standard MA`s.

averkie_skila Updated   
TVC:DXY   U.S. Dollar Index
Hi.
Another comment on signal compatibility.
In EMA crossing a true death cross should be considered the crossing of EMA100/EMA200.
This is usually always dangerous.
Since the model situation I want to discuss is now occurring on the daily DXY, let us take it.

1. So there is a fresh death cross printed on January 6.
2. There is no crossing of EMA100/EMA200 now.
3. The candles came out from under diagonal resistance
(what about the fact that the rate hike was already built into the conditions by the market?! lol).

But how do I know if the momentum is depleted?
The index has no volume...
With volatility outlook.

4. SQZMOM_LB shows a daily divergence and a squeeze entry before jumping up. Further rise in DXY will be supported by expansion momentum.
5. So I have some confusion about the death cross indication and its possible consequences...
If there is no support in the form of right away falling volatility for example...
That is why I am looking at other crosses.
6. It turns out that if I short DXY anyway more important indication would be EMA20 and EMA 50 (red and orange).
Since the move should be taken as early as possible and not wait for "iron" confirmations.
But it turns out that MA cross is too late for a short, and not convincing enough for a
continuation of the short at the moment when the cross finally happened...
7. In this case I think we're in for a ~108 level attack, which will prevent a cross at EMA100/200.

Comment:
OK, if anyone is offended by the "Education" status, I won't put it up.
You are responsible adults. You have to decide for yourselves whether it teaches you something or not. If you don't like any of this, just don't read me and don't believe me. I really appreciate unambiguity.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.